IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6802-6808

  Sivaprasad, Umasundari ^a   Warrier, Manoj R ^a,b,c,d   Gibson, Aaron M ^a   Chen, Weiguo ^a   Tabata, Yasuhiro ^a,e   Bass, Stacey A ^a   Rothenberg, Marc E ^b,c   Hershey, Gurjit K Khurana ^a,b,c  

^a Division of Asthma Research   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Genzyme Japan ^*  (United States)

^e Genzyme Japan KK   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CELL FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHILIA; EVALUATION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN SENSITIZATION; SKIN WATER LOSS; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; CELL LINE, TRANSFORMED; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HUMANS; INFANT, NEWBORN; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; INTERLEUKIN-4; KERATINOCYTES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; WATER LOSS, INSENSIBLE;

EID: 78650672614     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002118     Document Type: Article

References (46)

1. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113:651-657.
2. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
3. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
4. Wills-Karp, M. 2001. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107:9-18.
5. Hershey, G. K. 2003. IL-13 receptors and signaling pathways: an evolving web. J. Allergy Clin. Immunol. 111:677-690, quiz 691.
6. Hamid, Q., T. Naseer, E. M. Minshall, Y. L. Song, M. Boguniewicz, and D. Y. Leung. 1996. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98:225-231.
7. Lange, J., G. Ngoumou, S. Berkenheide, M. Moseler, J. Mattes, J. Kuehr, and M. V. Kopp. 2003. High interleukin-13 production by phytohaemagglutinin-and Der p 1-stimulated cord blood mononuclear cells is associated with the subsequent development of atopic dermatitis at the age of 3 years. Clin. Exp. Allergy 33:1537-1543.
8. Ohshima, Y., M. Yasutomi, N. Omata, A. Yamada, K. Fujisawa, K. Kasuga, M. Hiraoka, and M. Mayumi. 2002. Dysregulation of IL-13 production by cord blood CD4+ T cells is associated with the subsequent development of atopic disease in infants. Pediatr. Res. 51:195-200.
9. La Grutta, S., P. Richiusa, G. Pizzolanti, A. Mattina, G. B. Pajno, R. Citarrella, G. Passalacqua, and C. Giordano. 2005. CD4 (+) IL-13 (+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. Allergy 60:391-395.
10. McKenzie, A. N., X. Li, D. A. Largaespada, A. Sato, A. Kaneda, S. M. Zurawski, E. L. Doyle, A. Milatovich, U. Francke, N. G. Copeland, et al. 1993. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J. Immunol. 150:5436-5444.
11. Tazawa, T., H. Sugiura, Y. Sugiura, and M. Uehara. 2004. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch. Dermatol. Res. 295:459-464.
12. Zheng, T., M. H. Oh, S. Y. Oh, J. T. Schroeder, A. B. Glick, and Z. Zhu. 2009. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J. Invest. Dermatol. 129:742-751.
13. Aman, M. J., N. Tayebi, N. I. Obiri, R. K. Puri, W. S. Modi, and W. J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 271:29265-29270.
14. Caput, D., P. Laurent, M. Kaghad, J. M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271:16921-16926.
15. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497-501.
16. Miloux, B., P. Laurent, O. Bonnin, J. Lupker, D. Caput, N. Vita, and P. Ferrara. 1997. Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401:163-166.
17. Guo, J., F. Apiou, M. P. Mellerin, B. Lebeau, Y. Jacques, and S. Minvielle. 1997. Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 42:141-145. (Pubitemid 27215134)
18. Zhang, J. G., D. J. Hilton, T. A. Willson, C. McFarlane, B. A. Roberts, R. L. Moritz, R. J. Simpson, W. S. Alexander, D. Metcalf, and N. A. Nicola. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J. Biol. Chem. 272:9474-9480.
19. Wood, N., M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, et al. 2003. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197:703-709.
20. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, and T. A. Wynn. 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197:687-701.
21. Daines, M. O., and G. K. Hershey. 2002. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J. Biol. Chem. 277:10387-10393.
22. Fichtner-Feigl, S., W. Strober, K. Kawakami, R. K. Puri, and A. Kitani. 2006. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12:99-106.
23. Esche, C., A. de Benedetto, and L. A. Beck. 2004. Keratinocytes in atopic dermatitis: inflammatory signals. Curr. Allergy Asthma Rep. 4:276-284.
24. Akei, H. S., E. B. Brandt, A. Mishra, R. T. Strait, F. D. Finkelman, M. R. Warrier, G. K. Hershey, C. Blanchard, and M. E. Rothenberg. 2006. Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J. Allergy Clin. Immunol. 118:62-69.
25. David, M., D. Ford, J. Bertoglio, A. L. Maizel, and J. Pierre. 2001. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20:6660-6668.
26. Lü, Z. R., D. Park, K. A. Lee, J. W. Ryu, J. Bhak, L. Shi, D. Y. Lee, Y. D. Park, F. Zou, and J. M. Yang. 2009. Profiling the dysregulated genes of keratinocytes in atopic dermatitis patients: cDNA microarray and interactomic analyses. J. Dermatol. Sci. 54:126-129.
27. Khodoun, M., C. C. Lewis, C. Lewis, J. Q. Yang, T. Orekov, C. Potter, T. Wynn, M. Mentink-Kane, G. K. Hershey, M. Wills-Karp, and F. D. Finkelman. 2007. Differences in expression, affinity, and function of soluble (s) IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses J. Immunol. 179:6429-6438.
28. [Erratum in 2008 J. Immunol 180:664].
29. Brandt, E. B., and M. E. Rothenberg. 2001. Eosinophil levels in mice are significantly higher in small blood vessels than in large blood vessels. J. Allergy Clin. Immunol. 108:142-143.
30. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, et al. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2156.
31. Andrews, R. P., L. R. Rosa, M. O. Daines, and G. K. Khurana Hershey. 2001. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity. J. Immunol. 166:1716-1722.
32. Daines, M. O., W. Chen, Y. Tabata, B. A. Walker, A. M. Gibson, J. A. Masino, M. R. Warrier, C. L. Daines, S. E. Wenzel, and G. K. Hershey. 2007. Allergendependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy. J. Allergy Clin. Immunol. 119:375-383.
33. Daines, M. O., Y. Tabata, B. A. Walker, W. Chen, M. R. Warrier, S. Basu, and G. K. Hershey. 2006. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J. Immunol. 176:7495-7501.
34. Chen, W., U. Sivaprasad, Y. Tabata, A. M. Gibson, M. T. Stier, F. D. Finkelman, and G. K. Hershey. 2009. IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice. J. Immunol. 183:7870-7876.
35. Gupta, J., E. Grube, M. B. Ericksen, M. D. Stevenson, A. W. Lucky, A. P. Sheth, A. H. Assa'ad, and G. K. Khurana Hershey. 2008. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J. Allergy Clin. Immunol. 121:725-730.
36. Purwar, R., T. Werfel, and M. Wittmann. 2007. Regulation of IL-13 receptors in human keratinocytes. J. Invest. Dermatol. 127:1271-1274.
37. Ellis, C. N., L. A. Drake, M. M. Prendergast, W. Abramovits, M. Boguniewicz, C. R. Daniel, M. Lebwohl, S. R. Stevens, D. L. Whitaker-Worth, J. W. Cheng, and K. B. Tong. 2002. Cost of atopic dermatitis and eczema in the United States. J. Am. Acad. Dermatol. 46:361-370.
38. Zuo, L., P. C. Fulkerson, F. D. Finkelman, M. Mingler, C. A. Fischetti, C. Blanchard, and M. E. Rothenberg. 2010. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J. Immunol. 185:660-669.
39. David, M. D., J. Bertoglio, and J. Pierre. 2003. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression. Oncogene 22:3386-3394.
40. David, M., J. Bertoglio, and J. Pierre. 2002. TNF-alpha potentiates IL-4/IL-13-induced IL-13Ralpha2 expression. Ann. N. Y. Acad. Sci. 973:207-209.
41. Wongpiyabovorn, J., H. Suto, H. Ushio, K. Izuhara, K. Mitsuishi, S. Ikeda, A. Nakao, K. Okumura, and H. Ogawa. 2003. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. J. Dermatol. Sci. 33:31-40.
42. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta (1). J. Exp. Med. 194:809-821.
43. Kaviratne, M., M. Hesse, M. Leusink, A. W. Cheever, S. J. Davies, J. H. McKerrow, L. M. Wakefield, J. J. Letterio, and T. A. Wynn. 2004. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173:4020-4029.
44. Rahaman, S. O., P. Sharma, P. C. Harbor, M. J. Aman, M. A. Vogelbaum, and S. J. Haque. 2002. IL-13R (alpha) 2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res. 62:1103-1109.
45. Andrews, A. L., T. Nasir, F. Bucchieri, J. W. Holloway, S. T. Holgate, and D. E. Davies. 2006. IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J. Allergy Clin. Immunol. 118:858-865.
46. Tabata, Y., W. Chen, M. R. Warrier, A. M. Gibson, M. O. Daines, and G. K. Hershey. 2006. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms. J. Immunol. 177:7905-7912.